• Publications
  • Influence
Third universal definition of myocardial infarction.
ACCF : American College of Cardiology Foundation ACS : acute coronary syndrome AHA : American Heart Association CAD : coronary artery disease CABG : coronary artery bypass grafting CKMB : creatineExpand
  • 4,380
  • 215
Third universal definition of myocardial infarction.
AUTHORS/TASK FORCE MEMBERS CHAIRPERSONS Kristian Thygesen (Denmark),* Joseph S. Alpert (USA),* Harvey D. White (New Zealand),* Biomarker Subcommittee: Allan S. Jaffe (USA), Hugo A. Katus (Germany),Expand
  • 397
  • 31
  • PDF
European Society of Cardiology: Cardiovascular Disease Statistics 2017.
Aims The European Society of Cardiology (ESC) Atlas has been compiled by the European Heart Agency to document cardiovascular disease (CVD) statistics of the 56 ESC member countries. A major aim ofExpand
  • 334
  • 17
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
All DOIs are assessed prior to work commencing, and the ESC may decide to exclude any expert from a Guidelines activity based on the exclusion criteria as defined in the ESC Declaration andExpand
  • 216
  • 10
  • PDF
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
BACKGROUND Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication thatExpand
  • 375
  • 7
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial
A correction has been published: European Heart Journal, Volume 39, Issue 22, 7 June 2018, Pages 2105
  • 131
  • 6
  • PDF
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at
Atherosclerotic cardiovascular disease (ASCVD) underlies the thrombotic events intimately associated with myocardial infarction, a significant proportion of ischaemic strokes, as well as criticalExpand
  • 134
  • 5
  • PDF
Stent for Life in Portugal: This initiative is here to stay.
AIMS Portugal has one of the lowest rates of primary percutaneous coronary intervention (p-PCI) in Western Europe. This study assessed the progress of Portuguese p-PCI performance indicators one yearExpand
  • 39
  • 5
  • PDF
Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants
Gastrointestinal (GI) bleeding is a common complication among anticoagulated patients. Non‐vitamin K antagonist oral anticoagulants (NOACs) are associated with increased risk of GI (major andExpand
  • 45
  • 4
  • PDF